ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...

ALK’s new data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors: Denmark Monday, March 2, 2026, 18:00 Hrs [IST] ALK, a global sp ...

Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than the placebo group.

There are plenty of different schools of thought on the matter, but the truth depends on what type of car you have.

The patented Aerio™ platform was designed to meet the highest standards of device function and form from food allergies to modern medical countermeasuresGlen Allen, VA, Feb. 17, 2026 (GLOBE NEWSWIRE) ...

Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...

Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.

CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) DIJON, France - February 2, 2026 (7:15 a.m. CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), the ...

The ILUMYA Pen offers eligible patients a safe and effective treatment option that supports ease of use and may help reduce clinical visits through self-administration MUMBAI, India and BRAMPTON, ON, ...

Intas Pharmaceuticals has entered into an exclusive agreement with IntegriMedical, the technology leader behind India’s first needle-free injection system (N-FIS), to introduce this revolutionary ...

At the recent K 2025 show in Germany, Oerlikon HRSflow presented two innovative developments from its range of solutions for the automotive industry: The new, patent-pending Glow HRS technology and ...